rivastigmine has been researched along with Movement Disorders in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Leelavathi, M; Rosdinom, R; Suguna, M | 1 |
| de Tommaso, M; Difruscolo, O; Sciruicchio, V; Specchio, LM; Specchio, N | 1 |
| Barkhof, F; Lane, R; Scheltens, P; Staekenborg, SS; van der Flier, WM; van Straaten, EC | 1 |
| Chen, Y; Constantini, S; Shohami, E; Weinstock, M | 1 |
2 trial(s) available for rivastigmine and Movement Disorders
| Article | Year |
|---|---|
Effects of rivastigmine on motor and cognitive impairment in Huntington's disease.
Topics: Adult; Aged; Cognition Disorders; Demography; Female; Humans; Huntington Disease; Male; Middle Aged; Movement Disorders; Neuroprotective Agents; Phenylcarbamates; Prospective Studies; Rivastigmine; Severity of Illness Index; Trinucleotide Repeat Expansion | 2004 |
Neurological signs in relation to type of cerebrovascular disease in vascular dementia.
Topics: Aged; Aged, 80 and over; Aphasia; Basal Ganglia Diseases; Brain Infarction; Cerebrovascular Circulation; Cholinesterase Inhibitors; Dementia, Vascular; Female; Gait Disorders, Neurologic; Hemianopsia; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Movement Disorders; Phenylcarbamates; Prevalence; Reflex, Abnormal; Rivastigmine; Thalamus | 2008 |
2 other study(ies) available for rivastigmine and Movement Disorders
| Article | Year |
|---|---|
Pisa syndrome secondary to rivastigmine: a case report.
Topics: Aged; Benzodiazepines; Cholinesterase Inhibitors; Delusions; Dementia; Donepezil; Humans; Indans; Male; Movement Disorders; Olanzapine; Phenylcarbamates; Piperidines; Posture; Rivastigmine; Syndrome | 2012 |
Rivastigmine, a brain-selective acetylcholinesterase inhibitor, ameliorates cognitive and motor deficits induced by closed-head injury in the mouse.
Topics: Animals; Brain Edema; Carbamates; Cholinergic Antagonists; Cholinesterase Inhibitors; Cognition Disorders; Head Injuries, Closed; Male; Maze Learning; Mecamylamine; Memory; Mice; Movement; Movement Disorders; Muscarinic Antagonists; Neuroprotective Agents; Phenylcarbamates; Rivastigmine; Scopolamine | 1998 |